Alight is currently navigating a difficult structural transition characterized by persistent revenue contraction, which fell 2.6% in 2026Q1, and significant volatility in its GAAP earnings. While the company has aggressively reduced its goodwill from $3.5 bill...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 4, 2026 | $0.91+20.2% vs $0.76 | $511M+2.8% vs $497M |
Q2 2026 May 5, 2026 | $1.20+43.0% vs $0.84 | $534M+6.2% vs $503M |
Q1 2026 Feb 19, 2026 | $3.60-22.1% vs $4.62 | $653M-0.3% vs $655M |
Q4 2025 Nov 5, 2025 | $2.40-7.7% vs $2.60 | $533M-0.5% vs $536M |
Bank of New York Mellon Corp bought a new stake in Alight, Inc. (NYSE: ALIT) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 333,788 shares of the company's stock, valued at approximately $187,000. Bank of New York Mellon Corp owned approximately
Public Employees Retirement System of Ohio purchased a new stake in Alight, Inc. (NYSE: ALIT) during the second quarter, according to its most recent 13F filing with the SEC. The firm purchased 62,146 shares of the company's stock, valued at approximately $35,000. Public Employees Retirement System of Ohio owned approximately 0.23% of Alight
DEERFIELD, Ill.--(BUSINESS WIRE)--Alight, Inc. (NYSE: ALIT), a leading benefits administration provider of health, wealth and leave solutions, today announced that Marquee Health, a CuraLinc company, has joined the Alight Partner Network, bringing biometric screenings, personalized health coaching and wellbeing engagement resources to employees' benefits experience. Marquee Health helps employers drive engagement and support lasting lifestyle change through an outcomes-driven suite of health an.
Alight stock has seen big sell-offs since last week's market close due to macroeconomic concerns. Treasury bond yields and oil prices are rising, and inflation concerns are increasingly shaping market dynamics.
Benchmark ALIT against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Alight, Inc. (ALIT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $12.54 | $330.33M | -0.11 | -3% | -136.91% | -115.58% | 26% | |
| $298.99 | $28.24B | 18.39 | -2.24% | 15.49% | 19.75% | — | |
| $174.06 | $85.27B | 21.28 | 7.57% | 15.6% | 26.87% | — | |
| $281.60 | $59.73B | 16.55 | 9.45% | 22.27% | 41.97% | — | |
| $88.57 | $2.24B | 27.09 | 2.52% | 3.21% | 10.4% | — | |
| $263.68 | $105.4B | 24.08 | 6.74% | 20.11% | 70.2% | — |
Alight, Inc. (ALIT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Alight, Inc. (ALIT) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 4, 2026·SEC
Jul 1, 2026·SEC
Jun 18, 2026·SEC
Get notified when ALIT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Alight, Inc. (ALIT) stock FAQ — growth, dividends, profitability & financials explained
Alight, Inc. (ALIT) reported $2.23B in revenue for fiscal year 2025. This represents a 3% decrease from $2.30B in 2017.
Alight, Inc. (ALIT) saw revenue decline by 3.0% over the past year.
Alight, Inc. (ALIT) reported a net loss of $2.03B for fiscal year 2025.
Yes, Alight, Inc. (ALIT) pays a dividend with a yield of 26.00%. This makes it attractive for income-focused investors.
Alight, Inc. (ALIT) has a return on equity (ROE) of -115.6%. Negative ROE indicates the company is unprofitable.
Alight, Inc. (ALIT) generated $249.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
